Fraud and Misconduct
in Biomedical Research
3rd Edition
Will be published approx. on 12. September 2001
Book
Hardback
268 pages
978-0-7279-1508-5 (ISBN)
Description
The definitive and only book in the world which deals exclusively with clinical research misconduct, recognising that - although it is not rife - its occurance at all requires recognition and action.
More details
Edition
3rd edition
Language
English
Place of publication
United States
Publishing group
John Wiley & Sons Inc
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 241 mm
Width: 161 mm
Thickness: 20 mm
Weight
544 gr
ISBN-13
978-0-7279-1508-5 (9780727915085)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Stephen Lock and Frank Wells are the authors of Fraud and Misconduct: in Biomedical Research, 3rd Edition, published by Wiley.
Content
Overview. Research Misconduct 1974 - 1990.
Research Misconduct: an editor's view.
The role of Research Ethics Committes.
A pharmaceutical company's approach to the threat of research fraud.
The role of the FDA, NIH and other bodies in the USA.
Paycheques on a Saturday night: The changing politics of research integrity in the United States.
Philosophy.
The Statistician.
Whistleblower.
The Investigator.
Expriences of Fraud and Misconduct:.
Norway.
Finland.
Denmark.
France.
Dealing with misconduct in Science: German efforts.
The British pharmaceutical Industry's response.
Prevention
Research Misconduct: an editor's view.
The role of Research Ethics Committes.
A pharmaceutical company's approach to the threat of research fraud.
The role of the FDA, NIH and other bodies in the USA.
Paycheques on a Saturday night: The changing politics of research integrity in the United States.
Philosophy.
The Statistician.
Whistleblower.
The Investigator.
Expriences of Fraud and Misconduct:.
Norway.
Finland.
Denmark.
France.
Dealing with misconduct in Science: German efforts.
The British pharmaceutical Industry's response.
Prevention